Page 3 - Capr Technology News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Capr technology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Capr Technology Today - Breaking & Trending Today

Short Interest in Capricor Therapeutics Inc (NASDAQ:CAPR) Grows By 27.3%

Capricor Therapeutics Inc (NASDAQ:CAPR – Get Free Report) was the target of a large growth in short interest in the month of August. As of August 31st, there was short interest totalling 401,500 shares, a growth of 27.3% from the August 15th total of 315,500 shares. Based on an average daily trading volume, of 125,500 […] ....

Geode Capital Management , Capricor Therapeutics Inc , Morgan Stanley , Tower Research Capital , Hightower Advisors , Get Free Report , Capricor Therapeutics , Therapeutics Stock Down , Tower Advisors , Research Capital , Capital Management , State Street Corp , Street Corp , Capricor Therapeutics Daily , Nasdaq Capr ,

Head-To-Head Review: Regeneron Pharmaceuticals (NASDAQ:REGN) & Capricor Therapeutics (NASDAQ:CAPR)

Capricor Therapeutics (NASDAQ:CAPR – Get Free Report) and Regeneron Pharmaceuticals (NASDAQ:REGN – Get Free Report) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, earnings, dividends, analyst recommendations, institutional ownership, risk and valuation. Earnings and Valuation This table compares Capricor Therapeutics […] ....

New York , United States , Zai Lab , Capricor Therapeutics Inc , Kiniksa Pharmaceuticals Ltd , Roche Pharmaceuticals , Intellia Therapeutics Inc , Regeneron Pharmaceuticals Inc , Alnylam Pharmaceuticals Inc , Regeneron Pharmaceuticals , Us Department Of Health , Biomedical Advanced Research Development Authority , Mitsubishi Tanabe Pharma Corporation , Human Services , Teva Pharmaceutical Industries Ltd , Capricor Therapeutics , Get Free Report , Regeneron Pharmaceutical , Given Capricor Therapeutic , Alnylam Pharmaceuticals , Kiniksa Pharmaceuticals , Zai Lab Limited , Intellia Therapeutics , Capricor Therapeutics Daily , Nasdaq Capr , Stock Comparison ,

Capricor Therapeutics Inc (NASDAQ:CAPR) Short Interest Up 14.0% in August

Capricor Therapeutics Inc (NASDAQ:CAPR – Get Free Report) saw a large growth in short interest in the month of August. As of August 15th, there was short interest totalling 315,500 shares, a growth of 14.0% from the July 31st total of 276,700 shares. Based on an average daily volume of 102,200 shares, the days-to-cover ratio […] ....

Charles Schwab Investment Management Inc , Virtu Financial , Renaissance Technologies , Hightower Advisors , Capricor Therapeutics Inc , Tower Research Capital , Get Free Report , Capricor Therapeutics , Research Capital , Schwab Investment Management , Tower Advisors , Capricor Therapeutics Daily , Nasdaq Capr ,

HC Wainwright Research Analysts Increase Earnings Estimates for Capricor Therapeutics Inc (NASDAQ:CAPR)

Capricor Therapeutics Inc (NASDAQ:CAPR – Free Report) – Research analysts at HC Wainwright raised their Q3 2023 earnings estimates for shares of Capricor Therapeutics in a research report issued on Tuesday, August 15th. HC Wainwright analyst J. Pantginis now anticipates that the biotechnology company will post earnings of ($0.32) per share for the quarter, up […] ....

Capricor Therapeutics Inc , Vanguard Group Inc , Goldman Sachs Group Inc , Dimensional Fund Advisors , Charles Schwab Investment Management Inc , Free Report , Capricor Therapeutics , Capricor Therapeutic , Fund Advisors , Schwab Investment Management , Street Corp , Goldman Sachs Group , Sachs Group , Get Free Report , Capricor Therapeutics Daily , Nasdaq Capr , Earnings Estimates , Hc Wainwright ,

Capricor Therapeutics (NASDAQ:CAPR) Stock Passes Above 50 Day Moving Average of $4.49

Capricor Therapeutics Inc (NASDAQ:CAPR – Free Report) crossed above its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of $4.49 and traded as high as $4.73. Capricor Therapeutics shares last traded at $4.49, with a volume of 51,733 shares. Analysts Set New Price Targets Several equities research analysts […] ....

Renaissance Technologies , Tower Research Capital , Virtu Financial , Capricor Therapeutics Inc , Charles Schwab Investment Management Inc , Hightower Advisors , Free Report , Capricor Therapeutics , Research Capital , Schwab Investment Management , Tower Advisors , Capricor Therapeutics Daily , Nasdaq Capr ,